Anna MacDonald
Science Writer
After obtaining a first-class honours degree in biological sciences from the University of East Anglia, Anna worked as a scientific conference producer before joining Technology Networks. As part of her role, Anna helps to coordinate coverage, working with key opinion leaders from industry and academia to produce content across all communities.
Latest Content
Infographic
Spatial Transcriptomics in Cancer
In this infographic, we explore spatial transcriptomics and how progress in this area is paving the way to a better understanding of cancer.
Industry Insight
A Paradigm Shift in Sepsis Diagnostics
In this interview, Rolland Carlson, PhD, CEO of Immunexpress, discusses sepsis and the company’s FDA cleared SeptiCyte® RAPID test, as well as a take on the company’s differentiated value and outlook.
Article
What Does the Endocannabinoid System Have To Do With Autism Spectrum Disorder?
To learn more about the link between endocannabinoids and ASD and how innovative models are helping to study the ECS and its effects on the developing brain, Technology Networks spoke to Drs. Karen Litwa and Ken Soderstrom from East Carolina University.
Industry Insight
Digitalization of the Lab: Benefits, Solutions and the Future
To learn more about how digitalization can benefit workflows in the lab and some of the innovative solutions that Eppendorf offers in this area, Technology Networks spoke to Ann-Claire Foetsch.
Industry Insight
Unlocking the Functional Antibody Repertoire
Technology Networks learns about serum epitope repertoire analysis and some of the applications it could benefit, including cancer diagnostics and COVID-19 studies.
Industry Insight
Developing a Sustainable Source of Squalene
Technology Networks spoke to Jason Ornstein and Barry Holtz to learn how Synshark and Phylloceuticals are working together to address current challenges associated with squalene supply and access.
Industry Insight
Developing Therapeutics for Huntington’s Disease: Challenges, Opportunities and the Future
Dr. Christian Landles explains why it is so challenging to develop therapeutics for rare diseases such as HD, and discusses the potential of approaches that target mutant huntingtin protein to improve treatment options for HD patients.
Industry Insight
Driving Forward Huntington’s Disease Research
Dr. Christian Landles highlights some of the progress made in recent years to improve our understanding of HD and its drivers.
Industry Insight
New Model Will Support Drug Discovery for Liver Disease NASH
To learn more about NASH “in-a-box” and how it can help to advance drug discovery for NASH, Technology Networks spoke to Dr. Audrey Dubourg.
Industry Insight
Harnessing the Potential of Bioelectronic Medicine To Treat Essential Tremors
Technology Networks spoke to Renee Ryan, Cala Health's CEO, to learn more about bioelectronic medicine and its use as a therapy for essential tremors.
Advertisement
